DexCom, Inc. (DXCM)
61.57
-1.13
(-1.80%)
USD |
NASDAQ |
Apr 24, 16:00
61.41
-0.16
(-0.26%)
After-Hours: 06:09
DexCom Market Cap : 23.70B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 158.35B |
| Insulet Corp. | 13.34B |
| Intuitive Surgical, Inc. | 170.78B |
| Tandem Diabetes Care, Inc. | 1.391B |
| Boston Scientific Corp. | 92.25B |
Market Cap Related Metrics
| PE Ratio | 29.42 |
| PS Ratio | 5.355 |
| PEG Ratio | 0.627 |
| Price to Book Value | 8.629 |
| Price to Free Cash Flow | 23.18 |
| Price | 61.57 |
| Earnings Yield | 3.40% |
| PEGY Ratio | 0.627 |
| Operating PE Ratio | 27.38 |
| Normalized PE Ratio | 29.42 |